Search research articles
Contact Us
Filters
Showing results (151-160 of 177) with videos related to
Page
of 18
Sort By:
Plos One
|
April 28, 2022
Effects of immune checkpoint inhibitor therapy resumption in patients with malignant tumors after moderate-to-severe immune-related adverse events
Machiko Kawahira, Shuji Kanmura, Keiko Mizuno, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 16, 2026
Circulating Tumor DNA Genomic Profiling in <sup>223</sup>Ra-Treated Metastatic Castration-Resistant Prostate Cancer: The KYUCOG-1901 Study
Masaki Shiota, Maki Fujiwara, Takayuki Sumiyoshi, et al.
Cancer Research
|
September 3, 2004
CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer
Hideki Enokida, Hiroaki Shiina, Mikio Igawa, et al.
European Urology Open Science
|
July 11, 2022
Enzalutamide Versus Abiraterone plus Prednisolone Before Chemotherapy for Castration-resistant Prostate Cancer: A Multicenter Randomized Controlled Trial
Kouji Izumi, Takashi Shima, Koji Mita, et al.
Journal of Clinical Medicine
|
June 24, 2022
Serum IgG4 Concentration Is a Potential Predictive Biomarker in Glucocorticoid Treatment for Idiopathic Retroperitoneal Fibrosis
Shoichiro Mukai, Naotaka Sakamoto, Hiroaki Kakinoki, et al.
The Prostate
|
September 20, 2024
Dose modification in enzalutamide and abiraterone plus prednisolone for castration-resistant prostate cancer: A subanalysis from the ENABLE study for PCa
Nobumichi Tanaka, Kouji Izumi, Yasushi Nakai, et al.
The Prostate
|
April 4, 2025
Efficacy and Safety of Enzalutamide and Abiraterone Plus Prednisolone in Elder Castration-Resistant Prostate Cancer Patients: A Sub-Analysis From the ENABLE Study
Takehiko Okamura, Kouji Izumi, Satoshi Kurokawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
January 9, 2024
Clinicopathological characteristics of adrenocortical carcinoma in the Kyushu-Okinawa area of Japan
Shotaro Nakanishi, Yumi Fukushima, Junichi Inokuchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2006
Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway
Shinji Urakami, Hiroaki Shiina, Hideki Enokida, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
February 2, 2026
Clinical Outcomes and Clinicopathological Features of Primary Urethral Carcinoma: A Multicenter Retrospective Study in Japan
Keita Kobayashi, Kei Daizumoto, Takuya Tsujino, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 177) with videos related to
Sort By:
Page
of 18
Plos One
|
April 28, 2022
Effects of immune checkpoint inhibitor therapy resumption in patients with malignant tumors after moderate-to-severe immune-related adverse events
Machiko Kawahira, Shuji Kanmura, Keiko Mizuno, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 16, 2026
Circulating Tumor DNA Genomic Profiling in <sup>223</sup>Ra-Treated Metastatic Castration-Resistant Prostate Cancer: The KYUCOG-1901 Study
Masaki Shiota, Maki Fujiwara, Takayuki Sumiyoshi, et al.
Cancer Research
|
September 3, 2004
CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer
Hideki Enokida, Hiroaki Shiina, Mikio Igawa, et al.
European Urology Open Science
|
July 11, 2022
Enzalutamide Versus Abiraterone plus Prednisolone Before Chemotherapy for Castration-resistant Prostate Cancer: A Multicenter Randomized Controlled Trial
Kouji Izumi, Takashi Shima, Koji Mita, et al.
Journal of Clinical Medicine
|
June 24, 2022
Serum IgG4 Concentration Is a Potential Predictive Biomarker in Glucocorticoid Treatment for Idiopathic Retroperitoneal Fibrosis
Shoichiro Mukai, Naotaka Sakamoto, Hiroaki Kakinoki, et al.
The Prostate
|
September 20, 2024
Dose modification in enzalutamide and abiraterone plus prednisolone for castration-resistant prostate cancer: A subanalysis from the ENABLE study for PCa
Nobumichi Tanaka, Kouji Izumi, Yasushi Nakai, et al.
The Prostate
|
April 4, 2025
Efficacy and Safety of Enzalutamide and Abiraterone Plus Prednisolone in Elder Castration-Resistant Prostate Cancer Patients: A Sub-Analysis From the ENABLE Study
Takehiko Okamura, Kouji Izumi, Satoshi Kurokawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
January 9, 2024
Clinicopathological characteristics of adrenocortical carcinoma in the Kyushu-Okinawa area of Japan
Shotaro Nakanishi, Yumi Fukushima, Junichi Inokuchi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 24, 2006
Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway
Shinji Urakami, Hiroaki Shiina, Hideki Enokida, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association
|
February 2, 2026
Clinical Outcomes and Clinicopathological Features of Primary Urethral Carcinoma: A Multicenter Retrospective Study in Japan
Keita Kobayashi, Kei Daizumoto, Takuya Tsujino, et al.
Page
of 18